JP2016506905A5 - - Google Patents

Download PDF

Info

Publication number
JP2016506905A5
JP2016506905A5 JP2015552077A JP2015552077A JP2016506905A5 JP 2016506905 A5 JP2016506905 A5 JP 2016506905A5 JP 2015552077 A JP2015552077 A JP 2015552077A JP 2015552077 A JP2015552077 A JP 2015552077A JP 2016506905 A5 JP2016506905 A5 JP 2016506905A5
Authority
JP
Japan
Prior art keywords
azide
saccharide
group
spacer
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015552077A
Other languages
English (en)
Japanese (ja)
Other versions
JP6719209B2 (ja
JP2016506905A (ja
Filing date
Publication date
Priority claimed from GBGB1300707.5A external-priority patent/GB201300707D0/en
Application filed filed Critical
Publication of JP2016506905A publication Critical patent/JP2016506905A/ja
Publication of JP2016506905A5 publication Critical patent/JP2016506905A5/ja
Application granted granted Critical
Publication of JP6719209B2 publication Critical patent/JP6719209B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015552077A 2013-01-15 2014-01-13 シクロアルキン誘導体化糖類 Active JP6719209B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1300707.5 2013-01-15
GBGB1300707.5A GB201300707D0 (en) 2013-01-15 2013-01-15 Compounds and processes
PCT/EP2014/050483 WO2014111344A1 (en) 2013-01-15 2014-01-13 Cycloalkyne derivatized saccharides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018246761A Division JP2019073528A (ja) 2013-01-15 2018-12-28 シクロアルキン誘導体化糖類

Publications (3)

Publication Number Publication Date
JP2016506905A JP2016506905A (ja) 2016-03-07
JP2016506905A5 true JP2016506905A5 (https=) 2017-02-09
JP6719209B2 JP6719209B2 (ja) 2020-07-08

Family

ID=47758014

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015552077A Active JP6719209B2 (ja) 2013-01-15 2014-01-13 シクロアルキン誘導体化糖類
JP2018246761A Withdrawn JP2019073528A (ja) 2013-01-15 2018-12-28 シクロアルキン誘導体化糖類
JP2020050828A Active JP7036854B2 (ja) 2013-01-15 2020-03-23 シクロアルキン誘導体化糖類

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018246761A Withdrawn JP2019073528A (ja) 2013-01-15 2018-12-28 シクロアルキン誘導体化糖類
JP2020050828A Active JP7036854B2 (ja) 2013-01-15 2020-03-23 シクロアルキン誘導体化糖類

Country Status (16)

Country Link
US (3) US11135300B2 (https=)
EP (1) EP2945641B1 (https=)
JP (3) JP6719209B2 (https=)
CN (1) CN105377282B (https=)
BR (1) BR112015016817B1 (https=)
CA (1) CA2897348C (https=)
CY (1) CY1122822T1 (https=)
DK (1) DK2945641T3 (https=)
ES (1) ES2774729T3 (https=)
GB (1) GB201300707D0 (https=)
HR (1) HRP20200351T1 (https=)
LT (1) LT2945641T (https=)
PL (1) PL2945641T3 (https=)
PT (1) PT2945641T (https=)
SI (1) SI2945641T1 (https=)
WO (1) WO2014111344A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201300707D0 (en) * 2013-01-15 2013-02-27 Novartis Ag Compounds and processes
SG11201807430WA (en) * 2016-03-04 2018-09-27 Euglena Co Ltd Antiviral agent and antiviral food
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
ES3024474T3 (en) 2016-12-30 2025-06-04 Vaxcyte Inc Polypeptide-antigen conjugates with non-natural amino acids
JP7295571B2 (ja) * 2018-02-05 2023-06-21 国立大学法人 宮崎大学 細胞標識剤及び細胞標識キット
CN116874636B (zh) 2018-06-14 2026-04-17 持田制药株式会社 新型交联海藻酸
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
EP4200268A4 (en) 2020-08-19 2024-10-16 Vaxcyte, Inc. CARRIER PROTEIN POLYSACCHARIDE CONJUGATION PROCESS
MX2023013434A (es) * 2021-05-28 2023-12-12 Pfizer Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y sus usos.
JP7804631B2 (ja) * 2022-11-22 2026-01-22 ファイザー・インク コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1777236T (pt) * 2002-03-26 2017-02-13 Glaxosmithkline Biologicals Sa Sacáridos modificados possuindo estabilidade melhorada em água para utilização como um medicamento
EP1812057A4 (en) 2004-11-01 2009-07-22 Brigham & Womens Hospital Modified Streptococci polysaccharides and their uses
GB0502095D0 (en) * 2005-02-01 2005-03-09 Chiron Srl Conjugation of streptococcal capsular saccharides
CN104529711B (zh) * 2007-11-21 2020-02-07 乔治亚大学研究基金公司 炔烃以及炔烃与1,3-偶极-官能化合物反应的方法
ITVI20090234A1 (it) * 2009-09-25 2011-03-26 Termotecniche Fraccaro S R L Off Dispositivo per il riscaldamento di ambienti ad alta efficienza energetica, nonche' sistema riscaldante comprendente tale dispositivo
US8765920B2 (en) * 2009-12-23 2014-07-01 The Scripps Research Institute Tyrosine bioconjugation through aqueous Ene-like reactions
DK2563753T6 (en) * 2010-04-27 2016-04-04 Synaffix Bv Fused cyclooctynforbindelser and their use in metal-free click-reactions
WO2012017701A1 (ja) * 2010-08-05 2012-02-09 株式会社ミュージックゲート いびき防止マスク
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
EP2621905B1 (en) 2010-09-27 2017-04-12 University Of Georgia Research Foundation, Inc. Methods including latent 1,3-dipole-functional compounds and materials prepared thereby
US20120208722A1 (en) * 2010-10-19 2012-08-16 Richard Dluhy Surface enhanced raman spectroscopy platforms and methods
DK2721045T3 (en) 2011-06-20 2017-07-24 Radiomedix Inc COMPOSITIONS, METHODS OF SYNTHESIS AND USE OF CARBOHYDRATE TARGETED AGENTS
WO2013078562A2 (en) * 2011-12-01 2013-06-06 Angiochem Inc. Targeted enzyme compounds and uses thereof
GB201300707D0 (en) * 2013-01-15 2013-02-27 Novartis Ag Compounds and processes

Similar Documents

Publication Publication Date Title
JP2016506905A5 (https=)
WO2008083174A3 (en) Compositions and methods for the treatment of infections and tumors
HRP20200351T1 (hr) Cikloalkinski derivati saharida
CY1125006T1 (el) Λιπαρα οξεα και η χρηση τους σε συνδυασμο με βιομορια
WO2018098269A3 (en) Peptide-containing linkers for antibody-drug conjugates
WO2009082818A8 (en) Novel c-21-keto lupane derivatives preparation and use thereof
SG158870A1 (en) Bendamustine pharmaceutical compositions for lyophilisation
WO2009082819A8 (en) Novel lupane derivatives
EP3318562A3 (en) Benzylbenzene derivatives and methods of use
WO2009106980A3 (en) Indazole derivatives
JP2012528865A5 (https=)
ATE409048T1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
WO2007062107A3 (en) Immunostimulatory oligoribonucleotides
CL2008003153A1 (es) Compuestos espiro condensados, agonistas de gpr40: composicion farmaceutica que comprende a uno de los compuestos; y el uso de los compuestos en la preparacion de medicamentos para el tratamiento de la diabetes, hiperglicemia, alteracion de tolerancia a la glucosa en ayuna, entre otras.
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
RU2015118581A (ru) Лиофилизированные препараты мелфалана флуфенамида
WO2009088838A3 (en) Triarylmethane analogs and their use in treating cancers
JP2017505777A5 (https=)
WO2015066053A8 (en) Targeted therapeutics
US11702443B2 (en) Therapeutic agents and methods
Tabakmakher et al. Normonanchocidins A, B and D, new pentacyclic guanidine alkaloids from the Far-Eastern marine sponge Monanchora pulchra
RU2013136895A (ru) Новое бициклическое соединение или его соль
RU2012150501A (ru) Противораковые стероидные лактоны, ненасыщенные в положении 7(8)
AR048336A1 (es) Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
WO2015009731A3 (en) Azacyclic constrained analogs of fty720